{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:06:53Z","timestamp":1768075613580,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jneuroim.2014.06.025","type":"journal-article","created":{"date-parts":[[2014,7,6]],"date-time":"2014-07-06T09:15:11Z","timestamp":1404638111000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"274","author":[{"given":"De-Hyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"R\u00f6tger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal C.M.","family":"Appeldoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Reijerkerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8026-3737","authenticated-orcid":false,"given":"Werner","family":"Gladdines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter J.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf A.","family":"Linker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.06.025_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13311-012-0160-7","article-title":"Treatment of acute relapses in multiple sclerosis","volume":"10","author":"Berkovich","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004150070172","article-title":"Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials","volume":"247","author":"Brusaferri","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","article-title":"Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation","volume":"164","author":"Gaillard","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jneuroim.2014.06.025_bb0025","doi-asserted-by":"crossref","first-page":"e82331","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00330-7","article-title":"Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders","volume":"117","author":"Gold","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0035","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s001150170057","article-title":"Glucocorticosteroid therapy in optic neuritis and multiple sclerosis. Evidence from clinical studies and practical recommendations","volume":"72","author":"Grauer","year":"2001","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nbd.2008.01.001","article-title":"Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"30","author":"Herrero-Herranz","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00415-008-0743-8","article-title":"Contribution of relapses to disability in multiple sclerosis","volume":"255","author":"Hirst","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2011.03.001","article-title":"Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis","volume":"152","author":"Hofkens","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0060","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijpharm.2011.02.060","article-title":"Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis","volume":"416","author":"Hofkens","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2012.03.005","article-title":"Neuronal NF-kappaB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination","volume":"246","author":"Lee","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0075","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation","volume":"8","author":"Linker","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.expneurol.2008.02.005","article-title":"Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations","volume":"211","author":"Linker","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0070","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awq179","article-title":"Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis","volume":"133","author":"Linker","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/17425247.2.3.465","article-title":"Liposomes in the treatment of inflammatory disorders","volume":"2","author":"Metselaar","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0095","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0100","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.50.6.1833","article-title":"Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study","volume":"50","author":"Oliveri","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0105","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1136\/ard.2009.108985","article-title":"Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis","volume":"68","author":"Rauchhaus","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0110","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1167\/iovs.13-13599","article-title":"Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation","volume":"55","author":"Reijerkerk","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Pt 7","key":"10.1016\/j.jneuroim.2014.06.025_bb0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/123.7.1431","article-title":"T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy","volume":"123","author":"Schmidt","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0120","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/awg176","article-title":"Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis","volume":"126","author":"Schmidt","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0125","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.4049\/jimmunol.1101604","article-title":"Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis","volume":"187","author":"Schweingruber","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.06.025_bb0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1750-3639.1998.tb00194.x","article-title":"Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology","volume":"8","author":"Storch","year":"1998","journal-title":"Brain Pathol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:25:07Z","timestamp":1759047907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572814001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0165572814001969"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.06.025","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}